Terry Hermiston

Terry Hermiston

Gründer bei Coagulant Therapeutics, Inc.

Health Technology
Commercial Services

Ursprung des Netzwerks ersten Grades von Terry Hermiston

EinheitArt der EinheitIndustrie
7
Holding Company Pharmaceuticals: Major 7
6
Holding Company Pharmaceuticals: Major 6
3
Subsidiary Pharmaceuticals: Major 3

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Terry Hermiston

UnternehmenSektorVerknüpfte PersonenHauptposition
BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Jon Wigginton

Corporate Officer/Principal

PEGASYSTEMS INC. Information Technology Services

Richard Jones

Director/Board Member

Pharmaceuticals: Major

David Kirn

Chief Tech/Sci/R&D Officer

INTERMUNE INC Biotechnology

Robin Steele

General Counsel

Pharmaceuticals: Major

Robin Steele

General Counsel

SUTRO BIOPHARMA, INC. Pharmaceuticals: Major

Jon Wigginton

Director/Board Member

Miscellaneous Commercial Services

David Kirn

Helena H. Chaye

Founder

Corporate Officer/Principal

Pharmaceuticals: Major

Richard Jones

Helena H. Chaye

Director/Board Member

Chief Executive Officer

College/University

David Kirn

Corporate Officer/Principal

MACROGENICS, INC. Pharmaceuticals: Major

Jon Wigginton

Chief Tech/Sci/R&D Officer

Engineering & Construction

Richard Jones

Corporate Officer/Principal

Pharmaceuticals: Major

Helena H. Chaye

Corporate Officer/Principal

Dalhousie University College/University

Helena H. Chaye

Graduate Degree

University of British Columbia College/University

Helena H. Chaye

Doctorate Degree

University of California, Berkeley College/University

David Kirn

Undergraduate Degree

The University of Colorado College/University

Robin Steele

Undergraduate Degree

University of Michigan College/University

Jon Wigginton

Doctorate Degree

General Government

David Kirn

Corporate Officer/Principal

Miscellaneous Commercial Services

David Kirn

Corporate Officer/Principal

Investment Managers

Richard Jones

Corporate Officer/Principal

Pharmaceuticals: Major

Jon Wigginton

Corporate Officer/Principal

Pharmaceuticals: Major

Jon Wigginton

Director/Board Member

Miscellaneous Commercial Services

Helena H. Chaye

Corporate Officer/Principal

Center for Cancer Research General Government

Jon Wigginton

Corporate Officer/Principal

University of California, Hastings College/University

Robin Steele

Graduate Degree

Fleet Investment Services, Inc.

Richard Jones

Chief Executive Officer

Medical/Nursing Services

David Kirn

Corporate Officer/Principal

Drugstore Chains

Robin Steele

Director/Board Member

New York University School of Law College/University

Robin Steele

Graduate Degree

4D MOLECULAR THERAPEUTICS, INC. Biotechnology

David Kirn

Founder

CHECKMATE PHARMACEUTICALS, INC. Biotechnology

Jon Wigginton

Director/Board Member

Pharmaceuticals: Major

Robin Steele

Director/Board Member

Medical Specialties

Robin Steele

Director/Board Member

DARÉ BIOSCIENCE, INC. Pharmaceuticals: Major

Robin Steele

Director/Board Member

Biotechnology

Jon Wigginton

Chief Tech/Sci/R&D Officer

Gladiator Biosciences, Inc.

Robin Steele

Director/Board Member

DTCP Management GmbH Investment Managers

Mankyu Park

Corporate Officer/Principal

Biotechnology

David Kirn

Founder

Miscellaneous Commercial Services

Jon Wigginton

President

CULLINAN THERAPEUTICS, INC. Pharmaceuticals: Major

Jon Wigginton

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Frank Misselwitz

Chief Tech/Sci/R&D Officer

Food: Specialty/Candy

Tom Leonard

Director/Board Member

Statistik

International

Vereinigte Staaten 42
Kanada 4
Vereinigtes Königreich 3
Vereinigte Arabische Emirate 2
Schweiz 2

Sektoral

Health Technology 22
Consumer Services 9
Commercial Services 8
Finance 5
Government 3

Operativ

Director/Board Member 31
Corporate Officer/Principal 22
Chief Tech/Sci/R&D Officer 9
Founder 6
Undergraduate Degree 5
  1. Börse
  2. Insiders
  3. Terry Hermiston
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT